Safety and clinical effectiveness of GLP1 receptor agonists in inflammatory bowel disease patients. Sehgal P, Lewis JD, Pickett-Blakely O, Nandi N, et al. Clin Gastroenterol Hepatol 2025 Jan 30:S1542-3565(25)00073.

Read + Share

Amedeo Smart

Independent Medical Education

Sehgal P, Lewis JD, Pickett-Blakely O, Nandi N, et al. Safety and clinical effectiveness of GLP1 receptor agonists in inflammatory bowel disease patients. Clin Gastroenterol Hepatol 2025 Jan 30:S1542-3565(25)00073.
PMID: 39892632